
Birlotib 100 Tablet
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Erlotinib (100mg)
Overview Birlotib 100 Tablet
Birlotib 100mg tablets are indicated for treating non-small cell lung and pancreatic cancers. Administer this medication on an empty stomach, or at least one hour before or two hours after meals. Continue treatment as directed by your physician; the duration is individualized based on response and your specific needs. Strictly adhere to your doctor's prescribed dosage. Incorrect or excessive use can lead to severe adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; do not discontinue treatment without your doctor's approval. Common side effects include nausea, vomiting, tiredness, skin rashes, and weight loss. Severe diarrhea warrants increased fluid intake or medical attention. Photosensitivity is a potential side effect; protective clothing and sunscreen are recommended outdoors. Report oral ulceration, vision changes, or respiratory problems to your doctor immediately. Your physician may order regular liver function tests during treatment. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment. Smoking cessation is advised as it may interfere with the medication's efficacy. Maintain a two-hour interval between Birlotib 100mg and antacids or other medications.
Uses of Birlotib 100 Tablet
Cancers of the pancreas and lung (non-small cell type)
Major Benefits of Birlotib 100 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Birlotib 100 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Birlotib 100 Tablet:
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Birlotib 100 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Birlotib 100 Tablet. Ingest the tablet whole; do not crush, chew, or divide it. Administer on an empty stomach.
How Birlotib 100 Tablet works:
Birlotib 100mg tablets are an anti-neoplastic agent targeting lung cancer. Lung cancer cells possess epidermal growth factor receptors (EGFRs) which regulate their proliferation. The drug functions by attaching to these EGFRs, thereby blocking the cancer-promoting signals they transmit and consequently limiting tumor expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Birlotib 100 Tablet may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Birlotib 100 Tablets during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in potentially fatal circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Birlotib 100 Tablet while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Birlotib 100 Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Birlotib 100 tablets are considered safe for individuals with kidney impairment; no dosage alteration is necessary. However, its administration is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with hepatic impairment should use Birlotib 100 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Birlotib 100 Tablet :
Omit any missed Birlotib 100 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Birlotib 100 Tablet
| Label | Value |
|---|---|
| Type of Compound | Benzopyrimidine compound |
| Potential for Dependence | None. |
| Type of Treatment | Cancer-fighting drugs |
